New prostate cancer drug shows promise in early trial
NCT ID NCT04898634
First seen Sep 30, 2025 · Last updated May 08, 2026 · Updated 25 times
Summary
This early-stage study tests a new drug called JNJ-78278343 for advanced prostate cancer that has spread. The drug works by redirecting the body's immune T-cells to attack cancer cells. The study involves 216 men and aims to find the safest and most effective dose, while monitoring side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM Hopital Timone
Marseille, 13005, France
-
Antoni van Leeuwenhoek
Amsterdam, 1066 CX, Netherlands
-
Centre Leon Berard
Lyon, 69373, France
-
Chongqing University Cancer Hospital
Chongqing, 400030, China
-
Columbia University Medical Center Herbert Irving Pavilion
New York, New York, 10032, United States
-
Erasmus MC
Rotterdam, 3015 GD, Netherlands
-
First Affiliated Hospital Of Wenzhou Medical College
Wenzhou, 325399, China
-
Hosp Univ Fund Jimenez Diaz
Madrid, 28040, Spain
-
Hosp Univ Hm Sanchinarro
Madrid, 28050, Spain
-
Hosp Virgen de La Victoria
Málaga, 29010, Spain
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
National Cancer Center Hospital East
Kashiwa, 277 8577, Japan
-
Peking University Third Hospital
Beijing, 100191, China
-
Sun Yat Sen University Cancer Center
Guangzhou, 510710, China
-
University of Washington
Seattle, Washington, 98195-9472, United States
-
Yokohama City University Medical Center
Yokohama, 232 0024, Japan
Conditions
Explore the condition pages connected to this study.